DynamiCure
MA - WalthamBiotechnology
Focus: DynamiCure is a public biotechnology company headquartered in Waltham, MA, focused on IO immunotherapy for oncology. The company is in early-stage clinical development with a lean pipeline spanning oncology, infectious disease, and rare disease.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
6
Should You Work at DynamiCure?
AI assessmentDynamiCure is a speculative play suitable only for risk-tolerant scientists willing to build early-stage IO programs with uncertain timelines and limited near-term commercial catalysts.
Why Work Here
- Early-stage pipeline with multiple Phase 1 IO programs (DCBY02, DCSZ11) in advanced solid tumors offers research scientists exposure to emerging immunotherapy mechanisms
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Nasal swab
Bronchopulmonary DysplasiaClinical Trials (1)
NCT07411261PremaBiom: Metatranscriptomics of the Respiratory Microbiome to Predict the Occurrence of Bronchopulmonary Dysplasia in Preterm Infants
N/AHelp build intelligence for DynamiCure
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.